POST Holdings Inc.

▲ Bull Case

• ◆Foodservice Structural Moat + Egg Pricing Reset: Michael Foods is the #1 US foodservice egg processor with oligopoly pricing power. HPAI shifted egg prices from $1–2/dozen (pre-2022) to $3–4+ (peak 2023); structural factors suggest a durable $2.50–3.00/dozen baseline rather than full reversion. Foodservice EBITDA is ~15–20% permanently elevated, adding $23–35M unmodeled EBITDA tailwind. This alone justifies +$15–20/share upside.
• ◆8th Avenue Integration Success + Catoggio Execution: 8th Avenue (plant-based + specialty protein, $880M acquisition) is on-track for FY26 close with integration costs within plan. Catoggio-led pet food acquisition (Smucker, 2023) delivered +25% synergy realization. First full-year 8th Avenue EBITDA contribution ($40–60M incremental) plus Catoggio's operational credibility could drive FY27 Adj EBITDA to $1,650M+ (vs FY26 guide $1,550–1,580M), justifying an 8.5–9.0x sum-of-the-parts multiple expansion. Implies $140–155/share.
• ◆Per-Share Compounding via Aggressive Buybacks Despite Leverage: POST has reduced share count from ~67M (FY24) to ~54M current = 19% reduction in 2 years. Combined with $50–100M incremental Adj EBITDA growth (FY26–FY27), the per-share EBITDA growth trajectory is 6–8% annually despite consolidated growth of 2–3%. The $600M new buyback extends this runway through FY28, supporting $130–145/share fair value by FY27 and $180–200 by FY28.

▼ Bear Case

• ◆Cereal Secular Decline Accelerates Beyond Consensus: Post Consumer Brands (49% of revenue, largest sub-segment RTE cereal ~$2.0–2.2B) has faced 10+ years of structural volume decline (−200–300 bps/yr). If category volume decline accelerates to −4–5%/yr due to private-label capture and premiumization away from POST's mass-tier brands, and if POST market share slips 100+ bps/yr, Post Consumer Brands organic growth could compress to −5%/yr. Over 3 years, this represents ~$300M revenue headwind, compressing consolidated Adj EBITDA by $40–60M. Implies $80–95/share.
• ◆HPAI Normalization Structures Egg Pricing Back to Pre-2022 Levels: The bull case assumes $2.50–3.00/dozen is durable. Bear case: HPAI subsides (vaccines, genetics improve), supply normalizes, and wholesale egg prices revert to $1.50–1.75/dozen structural baseline. If egg pricing normalizes by FY27 and volume softens concurrently, Foodservice EBITDA declines $40–60M from FY25 levels, erasing the bull-case Foodservice optionality. Consolidated FY27 Adj EBITDA stalls at $1,500M (vs bull guide $1,650M+), multiple compresses to 7.0–7.2x. Implies $105–115/share; minimal upside.
• ◆Catoggio Transition Execution Risk + Leverage Refinancing Creep: Catoggio is internal and well-prepared, but capital-allocation decisions (M&A multiples, buyback discipline, leverage band adherence) are material for per-share compounding. If Catoggio signals a strategy shift away from Vitale's aggressive playbook (e.g., prioritizes deleveraging, pauses buybacks), the per-share equity-return story stalls. Separately, FY27–FY28 debt maturities (2028–2029 stack ~$2.8B) refi into higher rates (+150–200 bps vs originals); every 50 bps rise = −$0.08/share earnings drag. Implies $95–105/share.

“Bull-case view (tilted-bullish sell-side consensus: 7 Buy / 2 Hold): POST trades at 7.8x EV/EBITDA, a ~17% discount to peer median (9.5x). The discount reflects temporary operational headwinds (HPAI cycle, CEO transition, 8th Avenue integration) that resolve in FY27. Once resolved, POST deserves an 8.5–9.0x sum-of-the-parts multiple because the business is a durable cash compounder with an excellent capital-allocation track record. Fair value: $130–145. Bear-case view (market consensus implied by 7.8x multiple): POST's leverage (4.4x) is at the upper end of management's comfort band and leaves limited M&A capacity. The largest segment (Post Consumer Brands, 49%) is in a structurally declining category with no organic growth lever. Foodservice egg pricing is cyclical (HPAI is temporary), not structural. The consolidated 6% ROIC is below cost of capital. Fair value: $100–115. Resolution mechanism: Q4 FY26 guidance (Nov 2026) and two quarters of Catoggio-era operational execution (through Q1 FY27) will settle whether FY27 organic growth stabilizes and EBITDA inflects higher or stalls.”

• ◆Q3 FY26 Earnings (Aug 2026): First quarter post-Iowa HPAI outbreak clear period. Management's ability to hold Foodservice margins (target: $60M+ segment EBITDA, ≥15.0% margin) vs. seasonal normalization will signal bull vs. bear case credibility.
• ◆Q4 FY26 + FY27 Guidance (Nov 2026): Flagship catalyst. Management releases FY27 Adj EBITDA guidance; if $1,600M+ midpoint (vs. FY26 guide $1,550–1,580M), market reprices multiple upward toward 8.5x. Also discloses 8th Avenue first-full-year contribution.
• ◆Catoggio First Full Quarter as Sole CEO (Q1 FY27, Feb 2027): Validates transition execution. Watch for: organic growth consistency (target ≥−2%), EBITDA margin hold (≥19.0%), buyback pace maintenance.
• ◆8th Avenue Synergy Confirmation (Q2 FY27, May 2027): Second full quarter of integration. Management should provide confidence on synergy run-rate and pathway to $45–50M annualized EBITDA.
• ◆Leverage Rolldown Trajectory (through FY28): Net debt reduction from organic FCF + 8th Avenue synergies should drive leverage from 4.4x toward 4.0x by FY27-end, 3.8x by FY28-end.

• ◆HPAI Resurgence or Normalization Shock (~20% probability): Foodservice egg pricing swings $50–100M EBITDA either direction. Bull case depends on $2.50–3.00/dozen durability; if prices revert to $1.50–1.75/dozen, Foodservice EBITDA drops $40–60M, erasing bull optionality.
• ◆Cereal Category Decline Accelerates (~25% probability): RTE cereal volume decline could accelerate to 500+ bps/yr due to trade-down and private-label share gain, causing Post Consumer Brands organic to slip to −5%/yr, compressing consolidated Adj EBITDA $40–60M.
• ◆Catoggio Execution Risk / Strategy Shift (~15% probability): CEO transition is low-disruption (internal + Vitale Exec Chair continuity), but capital-allocation decisions are key. If Catoggio freezes buybacks, pauses M&A, or shifts to aggressive deleveraging, per-share compounding stalls.
• ◆Leverage Refinancing Creep & Rate Exposure (~15% probability): 2028–2029 debt maturity stack ($2.8B) refi at +150–200 bps vs. originals = $25–30M incremental annual cash interest. Every 50 bps rise = −$0.08/share earnings drag.
• ◆8th Avenue Integration Missteps (~15% probability): 8th Avenue deal economics depend on $45–50M post-synergy EBITDA run-rate. If synergy realization <60% of target or writedown taken in FY27, cash-on-cash ROIC falls to 5–6%, undermining M&A track record.